Atreca Inc (BCEL)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | John A. Orwin |
| Employees: | 130 |
| Web site: | atreca.com |
|
835 INDUSTRIAL ROAD,, SUITE 400, SAN CARLOS, CA, 94070
650-595-2595
| |
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Atreca, Inc. discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechani® of action and target derived from an antibody identified using its discovery platform. It also developing APN-122597, a receptor tyrosine kinase that target tumor tissues.
Please log in first to see chart